154 related articles for article (PubMed ID: 8998124)
21. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.
Salomon F; Cuneo RC; Hesp R; Sönksen PH
N Engl J Med; 1989 Dec; 321(26):1797-803. PubMed ID: 2687691
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Aguilera A; Burgués S; Martínez-Ara J; Miguel JL; Gómez-Pan A; Selgas R
Am J Kidney Dis; 1998 Sep; 32(3):454-63. PubMed ID: 9740162
[TBL] [Abstract][Full Text] [Related]
23. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone.
Ellis KJ; Lee PD; Pivarnik JM; Bukar JG; Gesundheit N
J Clin Endocrinol Metab; 1996 Aug; 81(8):3033-8. PubMed ID: 8768870
[TBL] [Abstract][Full Text] [Related]
24. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
25. Low-dose growth hormone therapy reduces inflammation in HIV-infected patients: a randomized placebo-controlled study.
Lindboe JB; Langkilde A; Eugen-Olsen J; Hansen BR; Haupt TH; Petersen J; Andersen O
Infect Dis (Lond); 2016; 48(11-12):829-37. PubMed ID: 27417288
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone treatment in hemodialysis patients--a randomized, double-blind, placebo-controlled study.
Ericsson F; Filho JC; Lindgren BF
Scand J Urol Nephrol; 2004; 38(4):340-7. PubMed ID: 15669595
[TBL] [Abstract][Full Text] [Related]
27. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
[TBL] [Abstract][Full Text] [Related]
28. Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study.
Mulligan K; Tai VW; Schambelan M
J Clin Endocrinol Metab; 1998 May; 83(5):1542-7. PubMed ID: 9589652
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study.
Mauras N; George D; Evans J; Milov D; Abrams S; Rini A; Welch S; Haymond MW
Metabolism; 2002 Jan; 51(1):127-35. PubMed ID: 11782884
[TBL] [Abstract][Full Text] [Related]
30. Effects of short-term recombinant human growth hormone therapy on plasma leptin concentrations in dialysis patients.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Bajo MA; Aguilera A; Méndez J; Codoceo R; Selgas R
Nephrol Dial Transplant; 2002 Feb; 17(2):260-4. PubMed ID: 11812876
[TBL] [Abstract][Full Text] [Related]
31. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.
Osterziel KJ; Strohm O; Schuler J; Friedrich M; Hänlein D; Willenbrock R; Anker SD; Poole-Wilson PA; Ranke MB; Dietz R
Lancet; 1998 Apr; 351(9111):1233-7. PubMed ID: 9643742
[TBL] [Abstract][Full Text] [Related]
32. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
Albert SG; Haas MJ; Mooradian AD
Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome.
Byrne TA; Morrissey TB; Nattakom TV; Ziegler TR; Wilmore DW
JPEN J Parenter Enteral Nutr; 1995; 19(4):296-302. PubMed ID: 8523629
[TBL] [Abstract][Full Text] [Related]
34. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
35. What are the clinical benefits of correcting the catabolic state in haemodialysis patients?
Jensen PB; Hansen TB; Oxhøj H; Froberg K; Ekelund B; Nielsen FT; Pedersen FB
Br J Clin Pract Suppl; 1996 Aug; 85():47-51. PubMed ID: 8995031
[TBL] [Abstract][Full Text] [Related]
36. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
Storer TW; Woodhouse LJ; Sattler F; Singh AB; Schroeder ET; Beck K; Padero M; Mac P; Yarasheski KE; Geurts P; Willemsen A; Harms MK; Bhasin S
J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
[TBL] [Abstract][Full Text] [Related]
37. Effect of growth hormone, glutamine, and enteral nutrition on intestinal adaptation in patients with short bowel syndrome.
Guo M; Li Y; Li J
Turk J Gastroenterol; 2013; 24(6):463-8. PubMed ID: 24623283
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength.
Cuneo RC; Salomon F; Wiles CM; Hesp R; Sönksen PH
J Appl Physiol (1985); 1991 Feb; 70(2):688-94. PubMed ID: 2022560
[TBL] [Abstract][Full Text] [Related]
39. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study.
Scolapio JS; Camilleri M; Fleming CR; Oenning LV; Burton DD; Sebo TJ; Batts KP; Kelly DG
Gastroenterology; 1997 Oct; 113(4):1074-81. PubMed ID: 9322500
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of growth hormone therapy in malnourished hemodialysis patients.
Kotzmann H; Yilmaz N; Lercher P; Riedl M; Schmidt A; Schuster E; Kreuzer S; Geyer G; Frisch H; Hörl WH; Mayer G; Luger A
Kidney Int; 2001 Oct; 60(4):1578-85. PubMed ID: 11576376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
